Teva Pharmaceutical Industries Limited (TEVA) Presents at J.P. Morgan 42nd Annual Global Healthcare Conference (Transcript)

[ad_1]

Teva Pharmaceutical Industries Limited (NYSE:TEVA) J.P. Morgan 42nd Annual Global Healthcare Conference January 8, 2024 11:15 AM ET

Company Participants

Richard Francis – President, CEO & Director

Conference Call Participants

Christopher Schott – JPMorgan

Christopher Schott

Good morning, everybody. I’m Chris Schott, Firm Analyst at JPMorgan and it’s my pleasure to be introducing Teva today. From the company we have CEO, Richard Francis. Richard joined Teva roughly a year ago, can be said a very productive 2023 and looking forward to hearing about the setup for Teva going forward.

So with that, Richard, thanks for joining us, and we’ll jump to Q&A after your presentation.

Richard Francis

Thanks very much, Chris. Good morning, everybody. Delighted to be here. Yes, it’s been One year, One hell of a year where I think that the work we’ve done at Teva really transformed Teva quite a bit of change and put us on the path for continuous growth going forward. So very excited about that.

And let me walk you through a bit of what’s given me that optimism and some of the progress we’ve made in that first year. So when I was here last year, you should listen to my first week in the company, which is an interesting first week to have when you come in. This was sort of generally the questions I was been asked, how are you going to get the company back to growth? The company has been declining top line for many years. How are you going to turn the corner? What are the things that are going to drive that growth? What are the important assets?

And then the majority of questions like were around debt and litigation. And so that’s sort of what I arrived and literally a year on, I’m pleased to say the

[ad_2]
Source link

Leave a Reply

Your email address will not be published. Required fields are marked *